Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Net Income (Common)
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
Net Income (Common)
HK$494.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
6%
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Net Income (Common)
HK$2.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
30%
|
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
39%
|
CAGR 5-Years
33%
|
CAGR 10-Years
17%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Net Income (Common)
¥3.5B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Net Income (Common)
HK$3.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Net Income (Common)
-$42m
|
CAGR 3-Years
38%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Glance View
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
See Also
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income (Common)?
Net Income (Common)
494.1m
HKD
Based on the financial report for Jun 30, 2024, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income (Common) amounts to 494.1m HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%
Over the last year, the Net Income (Common) growth was -29%. The average annual Net Income (Common) growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been -5% over the past three years , -12% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet